MyAverix Finance
US · Healthcare
Cadrenal Therapeutics, Inc. Common Stock (CVKD)
Biotechnology
Cadrenal Therapeutics, Inc. Common Stock (CVKD) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for CVKD
Cadrenal Therapeutics, Inc. Common Stock (CVKD) — FAQ
What is CVKD's P/E ratio?
The price-to-earnings (P/E) ratio for Cadrenal Therapeutics, Inc. Common Stock (CVKD) is 18.00 (data as of 2026-03-24).
Does Cadrenal Therapeutics, Inc. Common Stock pay a dividend?
Dividend yield is not available in the current snapshot for Cadrenal Therapeutics, Inc. Common Stock (CVKD). Check the MyAverix Finance app for the latest dividend data.
What sector is Cadrenal Therapeutics, Inc. Common Stock in?
Cadrenal Therapeutics, Inc. Common Stock (CVKD) is classified in the Healthcare sector (Biotechnology industry).
What exchange is CVKD listed on?
CVKD is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.